Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
5,365,000
USD
|
7,977,000
USD
|
| Cash flows from (used in) operations before changes in working capital |
100,693,000
USD
|
90,031,000
USD
|
| Adjustments for decrease (increase) in trade and other receivables |
5,588,000
USD
|
8,520,000
USD
|
| Adjustments for increase (decrease) in trade and other payables |
5,059,000
USD
|
6,939,000
USD
|
| Adjustments for increase (decrease) in employee benefit liabilities |
2,764,000
USD
|
2,581,000
USD
|
| Adjustments for depreciation expense |
18,986,000
USD
|
16,400,000
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
2,942,000
USD
|
875,000
USD
|
| Adjustments for gain (loss) on disposals, property, plant and equipment |
380,000
USD
|
49,000
USD
|
| Income taxes paid, classified as operating activities |
22,384,000
USD
|
43,108,000
USD
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of financial instruments, classified as investing activities |
45,990,000
USD
|
9,948,000
USD
|
| Proceeds from sales or maturity of financial instruments, classified as investing activities |
28,069,000
USD
|
-
USD
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
5,918,000
USD
|
15,845,000
USD
|
| Dividends paid to non-controlling interests, classified as financing activities |
-
USD
|
12,505,000
USD
|